NCT07217522 Rutgers University Study of the Genetics of Pulmonary Hypertension
| NCT ID | NCT07217522 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rutgers, The State University of New Jersey |
| Condition | Pulmonary Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2025-08-23 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2025-08-23 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn more about how genes impact the risk of pulmonary hypertension. Anyone 18 or older living in the US is eligible, and a diagnosis of PH is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.
Eligibility Criteria
Inclusion Criteria: * age 18 years or older * currently living in the United States * able to understand and follow written instructions in English * have access to the internet and a computer, laptop, tablet or smart phone * willing to provide written informed consent for participation * willing to provide DNA via a saliva sample using a collection kit mailed to the study participant's home * willing to complete a survey with questions about health related to the study of pulmonary hypertension. Exclusion Criteria: * Age 17 or below * Not currently living in the United States * Not able to participate in an online research study in English
Contact & Investigator
Tara Matise, Ph.D.
PRINCIPAL INVESTIGATOR
Rutgers, The State University of New Jersey
Frequently Asked Questions
Who can join the NCT07217522 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07217522 currently recruiting?
Yes, NCT07217522 is actively recruiting participants. Contact the research team at rugcc-ph@rutgers.edu for enrollment information.
Where is the NCT07217522 trial being conducted?
This trial is being conducted at Piscataway, United States.
Who is sponsoring the NCT07217522 clinical trial?
NCT07217522 is sponsored by Rutgers, The State University of New Jersey. The principal investigator is Tara Matise, Ph.D. at Rutgers, The State University of New Jersey. The trial plans to enroll 10,000 participants.